NATCO Pharma Limited (NSE:NATCOPHARM)
India
· Delayed Price · Currency is INR 873.00
-5.80 (-0.66%)
Jun 26, 2025, 3:30 PM IST
NATCO Pharma Revenue
In the fiscal year ending March 31, 2025, NATCO Pharma had annual revenue of 44.30B INR with 10.68% growth. NATCO Pharma had revenue of 12.21B in the quarter ending March 31, 2025, with 13.95% growth.
Revenue
44.30B
Revenue Growth
+10.68%
P/S Ratio
3.55
Revenue / Employee
11.03M
Employees
4,016
Market Cap
157.40B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 44.30B | 4.28B | 10.68% |
| Mar 31, 2024 | 40.02B | 12.94B | 47.76% |
| Mar 31, 2023 | 27.09B | 7.62B | 39.17% |
| Mar 31, 2022 | 19.46B | -1.10B | -5.35% |
| Mar 31, 2021 | 20.56B | 1.41B | 7.37% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 525.78B |
| Divi's Laboratories | 93.60B |
| Cipla | 272.67B |
| Apollo Hospitals Enterprise | 217.94B |
| Zydus Lifesciences | 232.42B |
| Mankind Pharma | 122.07B |
| Aurobindo Pharma | 317.24B |
| Alkem Laboratories | 129.65B |
NATCO Pharma News
- 10 days ago - Natco Pharma shares dip 2% after company receives one observation from US FDA following Mekaguda API facility inspection - Business Upturn
- 10 days ago - Top stocks to watch today, June 16: NTPC, Godrej Properties, ONGC, Oil India, SpiceJet, Natco Pharma and more - Business Upturn
- 10 days ago - Stocks to watch on June 17: Syngene, Tata Motors, Vedanta, YES Bank, SpiceJet, Sun Pharma, Natco Pharma, Zydus, Ramkrishna Forging - Business Upturn
- 12 days ago - NATCO Pharma receives one observation after US FDA inspection at Mekaguda API facility - Business Upturn
- 4 weeks ago - Natco Pharma shares jump 4% as Q4 revenue jumps 14.3% YoY to Rs 1,221 crore - Business Upturn
- 4 weeks ago - Q4 earnings results today: IRCTC, Deepak Nitrite, Natco Pharma, SAIL, Cummins, Welspun Corp among key companies to report - Business Upturn
- 2 months ago - NATCO Pharma plans to launch generic Risdiplam in India, awaiting court clearance - Business Upturn
- 2 months ago - Natco Pharma shares fall 5% today as Trump warns of aggressive pharma tariffs - Business Upturn